USA 100 , 26102615 (2003)
Given recent concerns around both legitimate and fraudulent GLP-1s, supporting resources from USP come at a crucial time
With the effects seen of the GLP-1 family of drugs on preventing kidney damage in diabetes, liver disease (non-alcoholic or metabolic-associated steatosis, NASH/MASH), and addiction, this drug class is exceeding all expectations
- "Anabolic Safeguarding" Prescriptions: Co-prescribing progressive resistance training (minimum 2x weekly targeting major muscle groups) aligned with adequate dietary protein (1.2-1.5g/kg/day) to protect muscle protein synthesis during deficit
The body can interconvert between different cobalamin forms as needed
Our ER-trained nurses bring clinical expertise with a compassionate touch, ensuring your comfort and safety throughout the process